The Discussion about Status and Conceptions of Adverse Drug Reaction Monitoring Institution in Prefecture-level City of Guangdong

Chinese Journal of Pharmacovigilance ›› 2012, Vol. 9 ›› Issue (4): 222-223.

• Orginal Article • Previous Articles Next Articles

The Discussion about Status and Conceptions of Adverse Drug Reaction Monitoring Institution in Prefecture-level City of Guangdong

LI Liang-hua¹, DENG Jian-xiong²

1 Zhongshan Institute for Drug Control, Guangdong Zhongshan 528437, China;
2 Guangdong Center for ADR Monitoring, Guangdong Guangzhou 528000, China

Received:2011-12-08 Online:2012-04-10 Published:2015-08-10

Abstract

LI Liang-hua, DENG Jian-xiong. The Discussion about Status and Conceptions of Adverse Drug Reaction Monitoring Institution in Prefecture-level City of Guangdong[J]. Chinese Journal of Pharmacovigilance, 2012, 9(4): 222-223.

Add to citation manager EndNote|Ris|BibTeX

URL: https://zgywjj.magtechjournal.com/EN/

https://zgywjj.magtechjournal.com/EN/Y2012/V9/I4/222

[1]	ZHANG Meiwei, LI Keqian, YAO Keyu, ZHU Yan. Current Descriptions of Functions in Package Inserts of Chinese Herbal Patent Medicines [J]. Chinese Journal of Pharmacovigilance, 2025, 22(2): 193-196.
[2]	LI Wenlong, JIA Juanjuan, HUANG Haiwei, YAO Jing, ZHANG Chunqing, WANG Yan, ZHANG Hui. Developments and Prospects of Radiopharmaceuticals in China [J]. Chinese Journal of Pharmacovigilance, 2025, 22(1): 37-42.
[3]	WANG Dan, DONG Duo, TIAN Chunhua. Course of development of pharmocovigilance systems in China [J]. Chinese Journal of Pharmacovigilance, 2024, 21(7): 735-740.
[4]	SONG Fuyu, CAO Yi. Establishment of Key Performance Indicators for Drug Inspection [J]. Chinese Journal of Pharmacovigilance, 2024, 21(12): 1411-1414.
[5]	ZHAO Xuan, GUO Jing, CHEN Ning, MEI Long, ZHENG Tingting, ZHANG Lifang, ZHANG Wei. Discuss the safety management of medical toxic drugs in medical institutions [J]. Chinese Journal of Pharmacovigilance, 2023, 20(6): 705-708.
[6]	ZHENG Yujing, ZHAO Zinan, JIN Pengfei, ZHAO Fei, HU Xin, ZHANG Yatong. Active monitoring of adverse reactions of capecitabine-induced hand-foot syndrome based on the hospital information system [J]. Chinese Journal of Pharmacovigilance, 2023, 20(4): 441-443.
[7]	HU Biyuan, WANG Jing, ZHENG Weiqi, HU Hongping, CHEN Yongwu. Suicidal tendency and paresthesia induced by voriconazole: a case report [J]. Chinese Journal of Pharmacovigilance, 2023, 20(4): 469-472.
[8]	ZHONG Yingying, WANG Zhao, ZUO Tiantian, LI Yaolei, LI Hailiang, MA Shuangcheng. Research progress on detection and risk assessment of exogenous heavy metals and related elements in Codonopsis Radix [J]. Chinese Journal of Pharmacovigilance, 2023, 20(11): 1309-1315.
[9]	YANG Miao, YANG Li, ZHAO Zhigang. Current applications and rationality of ribavirin in pediatrics in seven cities in China [J]. Chinese Journal of Pharmacovigilance, 2022, 19(4): 408-412.
[10]	LI Lan, KONG Fanyao, ZHU Ying, SHEN Lu. Developments and Suggestions on Cosmetics Adverse Reaction Monitoring in China [J]. Chinese Journal of Pharmacovigilance, 2021, 18(9): 850-854.
[11]	WANG Dan, REN Jingtian, WU Guizhi, XIONG Weiyi, TANG Ren, PANG Yu, FAN Rong, YANG Le. Significance of Good Pharmacovigilance Practice in the Construction of China Pharmacovigilance System [J]. Chinese Journal of Pharmacovigilance, 2021, 18(6): 501-503.
[12]	GENG Hongjiao, WANG Lianxin, XIE Yanming. Pharmacovigilance of Chinese Medicine in Medical Institutions [J]. Chinese Journal of Pharmacovigilance, 2021, 18(6): 552-555.
[13]	SA Rina, ZHANG Bing, LIN Zhijian, WANG Xiaofang, ZHANG Xiaomeng. Pharmacovigilance of Traditional Chinese Medicine in Pharmaceutical Care in Medical Institutions [J]. Chinese Journal of Pharmacovigilance, 2021, 18(5): 422-426.
[14]	FENG Yanan, LIU Xinxin, LI Yonghui, WANG Fang, GUO Ruifeng. Challenges to Pharmacovigilance by Medical Institutions under the New Drug Administration Law [J]. Chinese Journal of Pharmacovigilance, 2020, 17(9): 572-573.
[15]	HUANG Yuan, WANG Chenggang, WU Shifu, WANG Ling, TIAN Yuejie, WU Chen, WANG Xiaojun. Drug Abuse Monitoring Models in Medical Institutions in China [J]. Chinese Journal of Pharmacovigilance, 2020, 17(9): 607-612.

The Discussion about Status and Conceptions of Adverse Drug Reaction Monitoring Institution in Prefecture-level City of Guangdong

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics